Resveratrol Alleviates Dextran Sulfate Sodium-Induced Acute Ulcerative Colitis in Mice by Mediating PI3K/Akt/ VEGFA Pathway (vol 12, 693982, 2021)

被引:0
|
作者
Zhu, F.
Zheng, J.
Xu, F.
Xi, Y.
Chen, J.
Xu, X.
机构
关键词
resveratrol; ulcerative colitis; phosphoinositide; 3-kinase; protein kinase B; vascular endothelial growth factor A;
D O I
10.3389/fphar.2021.797101
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Preventive Effect of Lycopene in Dextran Sulfate Sodium-Induced Ulcerative Colitis Mice through the Regulation of TLR4/TRIF/NF-κB Signaling Pathway and Tight Junctions
    Li, Yaping
    Pan, Xiao
    Yin, Mingyuan
    Li, Cuiping
    Han, Lirong
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2021, 69 (45) : 13500 - 13509
  • [42] Diallyl trisulfide alleviates dextran sulphate sodium-induced colitis in mice by inhibiting NLRP3 inflammasome activation via ROS/Trx-1 pathway
    He, Yue
    Xiao, Ling
    Zhang, Jing
    Zhu, Yanrong
    Guo, Yilei
    Xia, Yufeng
    Zhao, Huatou
    Wei, Zhifeng
    Dai, Yue
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 135 (05) : 593 - 606
  • [43] Ilex rotunda Thunb Protects Against Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Restoring the Intestinal Mucosal Barrier and Modulating the Oncostatin M/Oncostatin M Receptor Pathway
    Li, Yao
    Yang, Xu
    Yuan, Jia-ni
    Lin, Rui
    Tian, Yun-yuan
    Li, Yu-xin
    Zhang, Yan
    Wang, Xu-fang
    Xie, Yan-hua
    Wang, Si-wang
    Zheng, Xiao-hui
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [44] Dehydroevodiamine Alleviates Ulcerative Colitis by Inhibiting the PI3K/AKT/NF-κB Signaling Pathway via Targeting AKT1 and Regulating Gut Microbes and Serum Metabolism
    Ma, Xiao
    Hu, Qichao
    Jiang, Tao
    Chen, Yuan
    Zhang, Wenwen
    Gao, Pan
    Zeng, Jinhao
    Efferth, Thomas
    MOLECULES, 2024, 29 (17):
  • [45] Cryptotanshinone ameliorates dextran sulfate sodium-induced murine acute and chronic ulcerative colitis via suppressing STAT3 activation and Th17 cell differentiation
    Fan, Li-Ming
    Zhang, Yu-Qin
    Chen, Ya-Ping
    Chen, Lin-Lin
    Xu, Wei-Heng
    Nan, Li-Hong
    Xu, Wei
    Lu, Bin
    Wang, Yan
    Chu, Ke-Dan
    Zhang, Jun-Ping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 108
  • [46] Protective effect of soluble dietary fiber from Rosa roxburghii Tratt residue on dextran sulfate sodium-induced ulcerative colitis by regulating serum metabolism and NF-κB pathway in mice
    Li, Lilang
    Zhang, Xiang
    Wang, Li
    Gao, Ming
    Wang, Yu
    Zhang, Zhengrong
    Yang, Xiaosheng
    Yang, Juan
    JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2024, 104 (12) : 7258 - 7270
  • [47] Cinnamaldehyde Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice by Modulating TLR4/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation
    Tan, Xiaofen
    Wen, Yifan
    Han, Zhijun
    Su, Xuyang
    Peng, Jing
    Chen, Feng
    Wang, Yadong
    Wang, Tianming
    Wang, Changzhong
    Ma, Kelong
    CHEMISTRY & BIODIVERSITY, 2023, 20 (02)
  • [48] Resveratrol Protects PC12 Cells from High Glucose-Induced Neurotoxicity Via PI3K/Akt/FoxO3a Pathway
    Mi-Hua Liu
    Cong Yuan
    Jun He
    Tian-Ping Tan
    Shao-Jian Wu
    Hong-Yun Fu
    Jun Liu
    Shan Yu
    Yu-Dan Chen
    Qun-Fang Le
    Wei Tian
    Heng-Jing Hu
    Yuan Zhang
    Xiao-Long Lin
    Cellular and Molecular Neurobiology, 2015, 35 : 513 - 522
  • [49] Trans-10-Hydroxy-2-Decenoic Acid Alleviates Dextran Sulfate Sodium-Induced Colitis in Mice via Regulating the Inflammasome-Mediated Pyroptotic Pathway and Enhancing Colonic Barrier Function
    Huang, Shanshan
    Tao, Ranran
    Zhou, Jiefei
    Qian, Linxi
    Wu, Jiang
    MOLECULAR NUTRITION & FOOD RESEARCH, 2022, 66 (12)
  • [50] Camellia nitidissima Chi extract ameliorates dextran sulfate sodium-induced acute ulcerative colitis in mice by inhibiting TLR4/NF-κB-mediated inflammatory activation
    Li, Lirong
    Huang, Rui
    Li, Wenwen
    Yao, Dengjie
    Zhang, Beibei
    Li, Mengna
    Luo, Shunan
    Qin, Yu
    Zhang, Wenwen
    INFLAMMOPHARMACOLOGY, 2025,